Next Generation Antibody Therapeutics Market is estimated to reach USD 5.53 billion by 2021 | Market Data Forecast
Next Generation Antibody Therapeutics market size was around USD 3 billion in 2017. It is expected to grow at a CAGR of 13% to reach USD 5.53 billion by 2022.
(EMAILWIRE.COM, March 22, 2018 ) Next generation antibody therapeutics have high efficiency and are more safe. Rapid advancements in monoclonal antibodies technology is the reason for this. These advances have improved bifunctional properties, decreased functional size along with immunogenicity. Several medical conditions like cancer; autoimmune diseases etc. are treated using these technologies because of its enhanced properties.
Explore More Information about report @ https://www.marketdataforecast.com/market-reports/next-generation-antibody-therapeutics-market-5406/
Rising number of cases of chronic diseases, rapid advancements in technology, higher investment in R&D and increasing healthcare expenditure are the primary drivers of market growth.
On the other hand, strict administrative guidelines and regulatory requirements and inordinate delays in approval for new drugs along with their high costs are the primary restraints of market growth.
The market is segmented by therapeutic application and by technology. Classification by therapeutic application entails Oncology and Autoimmune/Inflammatory Diseases. Classification by technology entails Antibody-Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, and Biosimilar Antibody Products. Biosimilar antibody products in the technology segment accounted for the largest market share thereby dominating the market in the forecast period. Oncology sub-category in the therapeutics application market category captured largest market share and is expected to remain in the lead till 2022.
Classification by geography entails North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America dominates the market with the largest market share. US is the leader in the North American market. Europe is the second largest market and is expected to remain so though bridging the deficit with North America towards the tail end of the forecast period. Asia Pacific is likely to be the fastest growing market with the highest CAGR in the forecast period. Economic boom in the emerging economies of India and China are the reasons for this. Latin America is anticipated to experience sluggish growth while MEA continues to be the least attractive market in the forecast period.
Key players in the market include Roche, Seattle Genetics, Takeda, Dyax Corp., and Immunogen. Other players in the market include Amgen, Inc., Biogen, Kyowa Hakko Kirin Co., Ltd., AstraZeneca, Pfizer, Inc., and Xencor, Inc.
Request free sample @ https://www.marketdataforecast.com/market-reports/next-generation-antibody-therapeutics-market-5406/request-sample
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillsets dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Explore More Information about report @ https://www.marketdataforecast.com/market-reports/next-generation-antibody-therapeutics-market-5406/
Rising number of cases of chronic diseases, rapid advancements in technology, higher investment in R&D and increasing healthcare expenditure are the primary drivers of market growth.
On the other hand, strict administrative guidelines and regulatory requirements and inordinate delays in approval for new drugs along with their high costs are the primary restraints of market growth.
The market is segmented by therapeutic application and by technology. Classification by therapeutic application entails Oncology and Autoimmune/Inflammatory Diseases. Classification by technology entails Antibody-Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, and Biosimilar Antibody Products. Biosimilar antibody products in the technology segment accounted for the largest market share thereby dominating the market in the forecast period. Oncology sub-category in the therapeutics application market category captured largest market share and is expected to remain in the lead till 2022.
Classification by geography entails North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America dominates the market with the largest market share. US is the leader in the North American market. Europe is the second largest market and is expected to remain so though bridging the deficit with North America towards the tail end of the forecast period. Asia Pacific is likely to be the fastest growing market with the highest CAGR in the forecast period. Economic boom in the emerging economies of India and China are the reasons for this. Latin America is anticipated to experience sluggish growth while MEA continues to be the least attractive market in the forecast period.
Key players in the market include Roche, Seattle Genetics, Takeda, Dyax Corp., and Immunogen. Other players in the market include Amgen, Inc., Biogen, Kyowa Hakko Kirin Co., Ltd., AstraZeneca, Pfizer, Inc., and Xencor, Inc.
Request free sample @ https://www.marketdataforecast.com/market-reports/next-generation-antibody-therapeutics-market-5406/request-sample
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillsets dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results